Lab
Collaborative Laboratory Services LLC
Collaborative Laboratory Services LLC was paid $1.55M by Medicaid between Jan 2018 and Dec 2024, across 69 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 14% of everything it billed.
33Billing provider infoCOLLABORATIVE LABORATORY SERVICES LLC
OTTUMWA, IA 52501
OTTUMWA, IA 52501
33aNPI1871685628assigned 09/29/2006
33bProvider typeClinical Medical Laboratory
28Total paid$1.55M
24GClaims105,110
24DCodes billed69
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Iowa
Rank by total paid#8 of 35
Median peer was paid$42K
This provider vs. median37×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official LAWRENCE, CHARLOTTE controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 17,118 | $187K | |
| 2019 | 18,286 | $245K | |
| 2020 | 13,253 | $182K | |
| 2021 | 18,290 | $374K | |
| 2022 | 17,007 | $298K | |
| 2023 | 13,333 | $170K | |
| 2024incomplete | 7,823 | $93K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 14% | 3,000 | 2,899 | $213K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 11% | 5,719 | 5,395 | $177K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 11% | 5,719 | 5,395 | $177K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 5.9% | 2,952 | 2,784 | $91K |
| 80050 | General health panel | 5.4% | 1,841 | 1,782 | $84K |
| 80055 | 4.5% | 1,693 | 1,601 | $70K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 4.4% | 2,969 | 2,868 | $68K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 4.1% | 2,673 | 2,541 | $63K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 3.9% | 1,551 | 1,446 | $60K |
| 80053 | Comprehensive metabolic panel | 3.5% | 6,542 | 6,104 | $55K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3.1% | 7,794 | 6,990 | $48K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 3.0% | 1,465 | 1,397 | $46K |
57 more codes
| 80061 | Lipid panel | 2.7% | 3,934 | $42K |
| 84443 | Thyroid stimulating hormone (TSH) | 2.6% | 3,163 | $40K |
| 87088 | 2.5% | 5,740 | $39K | |
| 36415 | Collection of venous blood by venipuncture | 2.5% | 12,983 | $38K |
| 87077 | 1.3% | 2,741 | $19K | |
| 87102 | 1.2% | 2,435 | $18K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.1% | 537 | $18K |
| 82728 | 1.1% | 1,531 | $17K | |
| 87081 | 1.0% | 2,629 | $16K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,472 | $15K |
| 87186 | <1% | 2,055 | $15K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,818 | $12K |
| 87581 | <1% | 332 | $11K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,470 | $10K |
| 84439 | <1% | 1,411 | $10K | |
| 82607 | <1% | 633 | $8K | |
| 82950 | <1% | 1,827 | $8K | |
| 86140 | <1% | 1,665 | $7K | |
| 80305 | <1% | 598 | $6K | |
| 84702 | <1% | 369 | $4K | |
| 82570 | <1% | 937 | $4K | |
| 87070 | <1% | 445 | $3K | |
| 85651 | <1% | 958 | $3K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 262 | $3K |
| 83540 | <1% | 578 | $3K | |
| 82043 | <1% | 601 | $3K | |
| 85018 | <1% | 1,192 | $3K | |
| 81001 | <1% | 1,036 | $3K | |
| 85027 | <1% | 585 | $2K | |
| 85014 | <1% | 1,033 | $2K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 31 | $2K |
| 82746 | <1% | 146 | $2K | |
| 83735 | <1% | 325 | $2K | |
| 80076 | <1% | 223 | $1K | |
| 85610 | <1% | 583 | $1K | |
| 83550 | <1% | 134 | $878.33 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 17 | $703.48 |
| 82784 | <1% | 64 | $609.30 | |
| 83690 | <1% | 85 | $516.74 | |
| 83880 | <1% | 14 | $496.46 | |
| 88304 | <1% | 28 | $477.36 | |
| 86592 | <1% | 119 | $460.24 | |
| 82565 | <1% | 93 | $368.48 | |
| 87999 | <1% | 159 | $328.40 | |
| 87625 | <1% | 12 | $309.72 | |
| 87205 | <1% | 67 | $261.02 | |
| 82150 | <1% | 39 | $249.82 | |
| 84153 | <1% | 14 | $211.07 | |
| 84520 | <1% | 43 | $140.39 | |
| 81003 | <1% | 80 | $107.56 | |
| 85048 | <1% | 95 | $89.50 | |
| 87147 | <1% | 15 | $85.40 | |
| 86803 | <1% | 12 | $74.74 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 12 | $65.50 |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | <1% | 582 | $59.98 |
| 85004 | <1% | 26 | $16.86 | |
| 0352U | 0% | 204 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLAWRENCE, CHARLOTTE (SECRETARY)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.